<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">38460057</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0975-0711</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology</Title><ISOAbbreviation>Indian J Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>Respiratory tract viral infections associated sepsis in patients with underlying liver disease: Viral sepsis an entity to look forward!</ArticleTitle><Pagination><StartPage>475</StartPage><EndPage>484</EndPage><MedlinePgn>475-484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12664-024-01536-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sepsis remains a global health burden associated with significant morbidity and mortality. Bacteria are known to be the predominant pathogens in sepsis; however, viral etiologies in sepsis are still under diagnosed. Respiratory viral pathogens have been previously linked to sepsis, but the knowledge of incidence, disease burden and mortality of viral-induced sepsis remains limited. This study aimed at understanding the role of respiratory viral infections in the causation of sepsis in liver disease patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective study, the clinical records of liver disease patients with influenza-like illness, whose requests for respiratory viral testing were received from January 2019 to December 2022, were reviewed. Respiratory viruses were identified using FilmArray 2.0 respiratory panel (BioFire Diagnostics, Utah, USA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1391 patients tested, a respiratory viral etiology was detected in 23%. The occurrence of sepsis was seen in 35%. Among these, isolated viral etiology with no other bacterial/fungal coinfection was found in 55% of patients. Rhinovirus/Enterovirus was found as the most common underlying viral etiology (23.4%). The sepsis prevalence was higher among patients with associated comorbidities (45%) and decompensated cirrhosis (84%). On multi-variable analysis, no factor was found independently associated with sepsis-related mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study underlines the importance of isolated viral etiology in causation of sepsis among liver disease patients. Patients with comorbidities, older age and decompensated cirrhosis are at an increased risk of developing sepsis and are associated with poorer outcomes. Accurate and timely identification of the viral etiology in sepsis would prevent the misuse of antibiotics and improve overall patient care.</AbstractText><CopyrightInformation>© 2024. Indian Society of Gastroenterology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Ekta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5237-216X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110 070, India. ektagaurisha@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samal</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiwall</LastName><ForeName>Rakhi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tevethia</LastName><ForeName>Harshvardhan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grover</LastName><ForeName>Malika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rani</LastName><ForeName>Nitiksha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prabhakar</LastName><ForeName>Tushar</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Manya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomar</LastName><ForeName>Arvind</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Reshu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Virology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kale</LastName><ForeName>Pratibha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khillan</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alam</LastName><ForeName>Seema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Paediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Gastroenterol</MedlineTA><NlmUniqueID>8409436</NlmUniqueID><ISSNLinking>0254-8860</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cirrhosis</Keyword><Keyword MajorTopicYN="N">Decompensated</Keyword><Keyword MajorTopicYN="N">Liver disease</Keyword><Keyword MajorTopicYN="N">RVI</Keyword><Keyword MajorTopicYN="N">Viral sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>9</Day><Hour>20</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>9</Day><Hour>11</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38460057</ArticleId><ArticleId IdType="doi">10.1007/s12664-024-01536-y</ArticleId><ArticleId IdType="pii">10.1007/s12664-024-01536-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–10. https://doi.org/10.1001/jama.2016.0287 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId><ArticleId IdType="pmc">4968574</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200–11. https://doi.org/10.1016/S0140-6736(19)32989-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32989-7</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId><ArticleId IdType="pmc">6970225</ArticleId></ArticleIdList></Reference><Reference><Citation>Phua J, Ngerng W, See K, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013;17:R202. https://doi.org/10.1186/cc12896 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12896</ArticleId><ArticleId IdType="pubmed">24028771</ArticleId><ArticleId IdType="pmc">4057416</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53. https://doi.org/10.1097/01.ccm.0000194725.48928.3a .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000194725.48928.3a</ArticleId><ArticleId IdType="pubmed">16424713</ArticleId></ArticleIdList></Reference><Reference><Citation>Southeast Asia Infectious Disease Clinical Research Network. Causes and outcomes of sepsis in southeast Asia: a multinational multicentre cross-sectional study. Lancet Glob Health. 2017;5:e157-67. https://doi.org/10.1016/S2214-109X(17)30007-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(17)30007-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X, Zhou F, Wang Y, Fan G, Cao B. Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment. Eur Respir Rev. 2020;29:200038.  https://doi.org/10.1183/16000617.0038-2020 .</Citation></Reference><Reference><Citation>Cillóniz C, Dominedò C, Magdaleno D, Ferrer M, Gabarrús A, Torres A. Pure viral sepsis secondary to community-acquired pneumonia in adults: Risk and prognostic factors. J Infect Dis. 2019;220:1166–71. https://doi.org/10.1093/infdis/jiz257 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz257</ArticleId><ArticleId IdType="pubmed">31115456</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Liu Y, Feng Z, et al. A fatal case of viral sepsis and encephalitis in a child caused by human adenovirus type 7 infection. Virol J. 2022;19:154. https://doi.org/10.1186/s12985-022-01886-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01886-z</ArticleId><ArticleId IdType="pubmed">36171632</ArticleId><ArticleId IdType="pmc">9517974</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395:1517–20. https://doi.org/10.1016/S0140-6736(20)30920-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30920-X</ArticleId><ArticleId IdType="pubmed">32311318</ArticleId><ArticleId IdType="pmc">7164875</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz M, Gualdoni GA, Winkler HM, et al. MxA for differentiating viral and bacterial infections in adults: a prospective, exploratory study. Infection. 2023;51:1329–37. https://doi.org/10.1007/s15010-023-01986-0 .</Citation></Reference><Reference><Citation>Poritz MA, Blaschke AJ, Byington CL, et al. Film Array, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One. 2011;6:e26047. [Erratum in: PLoS One. 2011;6. doi: 10.1371/annotation/468cfdcd-184c-42f7-a1d0-3b72a2f6a558] https://doi.org/10.1371/journal.pone.0026047 .</Citation></Reference><Reference><Citation>WHO. Global Epidemiological Surveillance Standards for Influenza. (Available from: http://www.who.int/influenza/resources/documents/WHO_Epidemiological_Influenza_Surveillance_Standards_2014.pdf ). Accessed on 5th July, 2023.</Citation></Reference><Reference><Citation>Fang W, Wu J, Cheng M, et al. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30:42. https://doi.org/10.1186/s12929-023-00926-2 .</Citation></Reference><Reference><Citation>Abumayyaleh M, Nuñez-Gil IJ, El-Battrawy I, et al. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score. Front Med (Lausanne). 2021;8:728102. https://doi.org/10.3389/fmed.2021.728102 .</Citation></Reference><Reference><Citation>Lin GL, McGinley JP, Drysdale SB, Pollard AJ. Epidemiology and Immune Pathogenesis of Viral Sepsis. Front Immunol. 2018;9:2147. https://doi.org/10.3389/fimmu.2018.02147 .</Citation></Reference><Reference><Citation>Premkumar M, Devurgowda D, Dudha S, et al. A/H1N1/09 Influenza is associated with high mortality in liver cirrhosis. J Clin Exp Hepatol. 2019;9:162–70. https://doi.org/10.1016/j.jceh.2018.04.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jceh.2018.04.006</ArticleId><ArticleId IdType="pubmed">31024197</ArticleId></ArticleIdList></Reference><Reference><Citation>Samal J, Agarwal R, Soni A, Pandey A, Thapar S, Gupta E. Coinfection of SARS-CoV-2 with other respiratory pathogens in patients with liver disease. Access Microbiol. 2022;4:acmi000456. https://doi.org/10.1099/acmi.0.000456 .</Citation></Reference><Reference><Citation>Sarin SK, Choudhury A, Lau GK, et al. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020;14:690–700. https://doi.org/10.1007/s12072-020-10072-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12072-020-10072-8</ArticleId><ArticleId IdType="pubmed">32623632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ 2019;366:l5021. https://doi.org/10.1136/bmj.l5021 .</Citation></Reference><Reference><Citation>Liu J, Zhao H, Feng Z, et al. A severe case of human rhinovirus A45 with central nervous system involvement and viral sepsis. Virol J. 2022;19:72. https://doi.org/10.1186/s12985-022-01799-x .</Citation></Reference><Reference><Citation>Bajpai V, Gupta E, Mitra LG, et al. Spectrum of respiratory viral infections in liver disease patients with cirrhosis admitted in critical care unit. J Lab Physicians. 2019;11:356–60. https://doi.org/10.4103/JLP.JLP_6_19 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/JLP.JLP_6_19</ArticleId><ArticleId IdType="pubmed">31929704</ArticleId><ArticleId IdType="pmc">6943874</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao YT, Tsai YH, Liao WT, Shen CJ, Shen CF, Cheng CM. Differential markers of bacterial and viral infections in children for point-of-care testing. Trends Mol Med. 2020;26:1118–32. https://doi.org/10.1016/j.molmed.2020.09.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2020.09.004</ArticleId><ArticleId IdType="pubmed">33008730</ArticleId><ArticleId IdType="pmc">7522093</ArticleId></ArticleIdList></Reference><Reference><Citation>Maras JS, Sharma S, Bhat A, et al. Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome. iScience. 2021;24:102823. https://doi.org/10.1016/j.isci.2021.102823 .</Citation></Reference><Reference><Citation>Piri R, Yahya M, Ivaska L, et al. Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute Infection. Microbiol Spectr. 2022;10:e0203121. https://doi.org/10.1128/spectrum.02031-21 .</Citation></Reference><Reference><Citation>Rhedin S, Eklundh A, Ryd-Rinder M, et al. Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children - The TREND study. Clin Microbiol Infect. 2022;28:1251–7. https://doi.org/10.1016/j.cmi.2022.05.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.05.008</ArticleId><ArticleId IdType="pubmed">35597507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtinen O, Broman N, Waris M, et al. Association of human myxovirus resistance protein A with severity of COVID-19. BMC Infect Dis. 2022;22:755. https://doi.org/10.1186/s12879-022-07753-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07753-0</ArticleId><ArticleId IdType="pubmed">36171547</ArticleId><ArticleId IdType="pmc">9517979</ArticleId></ArticleIdList></Reference><Reference><Citation>Self WH, Rosen J, Sharp SC, et al. Diagnostic accuracy of FebriDx: A rapid test to detect immune responses to viral and bacterial upper respiratory infections. J Clin Med. 2017;6:94. https://doi.org/10.3390/jcm6100094 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm6100094</ArticleId><ArticleId IdType="pubmed">28991170</ArticleId><ArticleId IdType="pmc">5664009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>